Anebulo Pharmaceuticals Inc ANEB:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:29 PM EDT
3.83quote price arrow down-0.04 (-1.03%)
Volume
4,777
52 week range
2.67 - 7.88
Loading...
  • Open3.82
  • Day High3.83
  • Day Low3.55
  • Prev Close3.87
  • 52 Week High7.88
  • 52 Week High Date02/01/22
  • 52 Week Low2.67
  • 52 Week Low Date06/17/22

Key Stats

  • Market Cap89.39M
  • Shares Out23.34M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-37.72

KEY STATS

  • Open3.82
  • Day High3.83
  • Day Low3.55
  • Prev Close3.87
  • 52 Week High7.88
  • 52 Week High Date02/01/22
  • 52 Week Low2.67
  • 52 Week Low Date06/17/22
  • Market Cap89.39M
  • Shares Out23.34M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-37.72

RATIOS/PROFITABILITY

  • EPS (TTM)-1.43
  • P/E (TTM)-2.68
  • Fwd P/E (NTM)-11.10
  • EBITDA (TTM)-6.99M
  • ROE (TTM)-870.07%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Anebulo Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing solutions for people suffering from cannabinoid overdose and substance addiction. The Company's lead product candidate, ANEB-001, is a potent, small molecule cannabinoid receptor antagonist, designed to address the unmet medical need for a specific antidote for cannabinoid overdose. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety...
Address
1415 Ranch Road 629 South, Suite 201
Lakeway, TX
78734
United States

Top Peers

SYMBOLLASTCHG%CHG
BLRX
BioLine RX Ltd
1.69-0.10-5.59%
ETNB
89Bio Inc
4.70+0.37+8.55%
AKTX
Akari Therapeutics PLC
1.43-0.03-2.05%
CYT
Cyteir Therapeutics Inc
2.47-0.03-1.20%
ENLV
Enlivex Therapeutics Ltd
5.11-0.04-0.78%